MPP+ enhances potassium-evoked striatal dopamine release through a omega-conotoxin-insensitive, tetrodotoxin- and nimodipine-sensitive calcium-dependent mechanism.
Chiueh
C C
CC
Laboratory of Cerebral Metabolism, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892.
Huang
S J
SJ
D015655:1-Methyl-4-phenylpyridinium / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D009553:Nimodipine / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D013779:Tetrodotoxin / Q000494:pharmacology; D020960:omega-Conotoxins
D010456:Peptides, Cyclic; D020960:omega-Conotoxins; C053423:Conus magus toxin; D013779:Tetrodotoxin; D009553:Nimodipine; D015655:1-Methyl-4-phenylpyridinium; D011188:Potassium; D002118:Calcium; D004298:Dopamine